The indirect catecholamine agonist methylphenidate (Ritalin) is the drug treatment of choice in attention deficit/hyperactivity disorder (AD/HD), one of the most common behavioral disorders of childhood (DSM-IV), although symptoms may persist into adulthood. Methylphenidate can enhance cognitive performance in adults and children diagnosed with AD/HD (Kempton et al., 1999; Riordan et al., 1999) and also in normal human volunteers on tasks sensitive to frontal lobe damage, including aspects of spatial working memory (SWM) performance (Elliott et al., 1997) . The present study investigated changes in regional cerebral blood flow (rCBF) induced by methylphenidate during performance of a self-ordered SWM task to define the neuroanatomical loci of the beneficial effect of the drug. The results show that the methylphenidate-induced improvements in working memory performance occur with task-related reductions in rCBF in the dorsolateral prefrontal cortex and posterior parietal cortex. The beneficial effects of methylphenidate on working memory were greatest in the subjects with lower baseline working memory capacity. This is to our knowledge the first demonstration of a localization of a drug-induced improvement in SWM performance in humans and has relevance for understanding the treatment of AD/HD.
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Methylphenidate is a stimulant drug related to amphetamine that acts to increase the synaptic concentration of dopamine and noradrenaline (catecholamines) by blocking their reuptake (Scheel-Kruger et al., 1977; Seeman and Madras, 1998) . Both of these neurotransmitters are known to affect performance of spatial working memory (SWM) tasks in monkeys (Arnsten, 1997) and humans (Coull et al., 1995; Elliott et al., 1997) . Local injection and iontophoretic application of specific dopaminergic (Bernardi et al., 1982; Sawaguchi et al., 1988) and noradrenergic agents (Arnsten and Goldman-Rakic, 1985) as well as electrophysiological measures (Bernardi et al., 1982) in the monkey have identified the lateral prefrontal cortex as a critical region by which these monoamine systems influence SWM processes. In addition, in humans, methylphenidate enhances performance of the SWM task used in the present study (Elliott et al., 1997) . However, the neural (cortical or subcortical) localization of the effects of stimulant medications, such as methylphenidate, on working memory performance has not been determined in human subjects. The prefrontal and temporal cortices can be hypothesized to be possible neuromodulatory sites of action because damage to these cortical areas impairs self-ordered SWM performance (Owen et al., 1996a) , and activations of the dorsolateral and ventrolateral prefrontal cortex (in addition to PPC) are observed during functional neuroimaging (Owen et al., 1996b) . In humans, direct approaches aimed at defining the neuroanatomical site of performance modulation by methylphenidate in vivo have only become possible with the advent of functional neuroimaging techniques.
Thus, we conducted the present study to examine the effects of methylphenidate on regional cerebral blood flow (rCBF) in normal volunteers using positron emission tomography (PET). Based on the results of previous studies (Mattay et al., 1996; Owen et al., 1996b; Elliott et al., 1997) , we predicted that methylphenidate would enhance spatial working memory performance and that this would be accompanied by changes in rCBF in regions of the frontal and parietal lobes known to be activated by the task (Owen et al., 1996b) .
MATERIALS AND METHODS
Procedure. The study protocol for this investigation was approved by the C ambridge L ocal Research Ethics Committee and the Administration of Radioactive Substances Advisory Council. Written informed consent was obtained for all subjects. For the study, 10 healthy right-handed male volunteers (mean age, 34.8 years; SD, 3.40) were seen on two occasions separated by 2 weeks. On each session volunteers were given either 40 mg of methylphenidate or placebo (lactose) presented in identical capsules. Imaging commenced ϳ90 min after ingestion of the capsule to maximize the levels of drug during the scans (Gualtieri et al., 1982) . Before scans or tablet ingestion on session 1, subjects were given a brief baseline assessment with the digit span test from the Weschler Adult Intelligence Scale -Revised, the National Adult Reading Test, and the spatial span test from the CAN TAB battery (Owen et al., 1996b) . In addition, subjects were trained on a simple version (four and six boxes) of the SW M task used during the activation scans. On each test session, cardiovascular measures and a set of 16 visual analog scale ratings (Bond and Lader, 1974) were taken before tablet ingestion, after scan 3 or 4, and after scan 6. For each session, six PET scans (each of 90 sec data acquisition) were obtained for each subject, two for each of three task conditions (see below). The order of administration of the tasks was randomized across the six scans for each subject. The General Electric Advance system was used to measure rCBF. For each scan subjects received a 20 sec intravenous bolus of H 2 15 O through a cannula in the left arm at a concentration of 300 Mbq /ml and flow rate of 10 ml /min before data acquisition.
Cognitive task . The two task conditions and control condition used were identical to those described by Owen et al. (1996b) . For the task conditions, subjects were presented either six ("easy") or twelve ("difficult") red circles on a touch-sensitive computer screen suspended above the scanner. For each problem, subjects were required to search through the array of red circles for blue tokens by touching each one to reveal its contents. The goal was to find all of the blue tokens, which were hidden behind the red circles. The key instruction was that, once a blue token had been found behind a particular red circle, that circle would not be used again to hide a token. Each circle was only used once to hide a token, and therefore two types of error were possible. A between-search error occurred when a subject returned to a circle in which they had previously found a blue token, and a within-search error occurred when a subject returned to a circle within the same search. The performance measure of errors described in Results refers to between-search errors. Subjects performed the task continually for 30 sec before, and for the 90 sec duration of, scan acquisition. Over this period of time, subjects performed between three and five task problems. The control condition was designed to have similar visual, spatial, and motor requirements as both of the task conditions. Eight circles were, therefore, presented on the computer screen, and the central one changed color at a rate of approximately once per second. On the color change, subjects were required to touch the central circle with the same finger used for the memory tasks.
Data anal ysis. Initially, individual three-dimensional (3-D) magnetic resonance imaging (MRI) was obtained (whole brain, 256 ϫ 256 ϫ 128 pixels) using a 0.5 T system. MRI images were resliced to be coregistered with the PET data to allow for anatomical localization of regions with statistically significant changes in rCBF between conditions. PET data were realigned (to individual MRI scans and to a standard brain), normalized (for global CBF), smoothed (using an isotropic Gaussian kernel of 16 mm), and analyzed using the Statistical Parametric Mapping 96 (SPM96) (Friston et al., 1995) package.
For the statistical analyses of the neuroimaging data, the general linear model, as implemented by SPM96 (Friston et al., 1995) , was used to estimate the blood flow changes between each condition for each voxel. Scan order was covaried using ANC OVA. For activations occurring in areas of the brain previously shown to be involved in performance of the working memory task (ventrolateral and dorsolateral prefrontal, premotor, and posterior parietal cortices), an intensity threshold (uncorrected for multiple comparisons) of p Յ 0.001 was applied. For other areas of the brain a corrected intensity threshold of p Յ 0.05 was applied. These thresholds, based on 3-D Gaussian random field theory, predict the likelihood of obtaining a false positive in an extended 3-D field.
Behavioral data for the cognitive tasks, cardiovascular measures, and subjective ratings on the visual analog scales were analyzed (using SPSS for the Apple Macintosh) using repeated-measures ANOVAs with session order as a between-subjects factor and drug and, where appropriate, time as within-subjects factors.
RESULTS

Effects of Ritalin of self-ordered spatial working memory performance
Analysis of the behavioral performance of subjects confirmed previous findings (Elliott et al., 1997) with subjects on methylphenidate making fewer between-search errors on the SWM task than when on placebo [mean and SEs of search errors per 12 circle problem on drug: 11.5 (3.32) and placebo: 16.1 (4.48); F (1,8) ϭ 5.57; p ϭ 0.046]. The drug had no effect on within-search errors [drug: 3.24 (1.19) and placebo: 4.95 (2.25); F (1, 8) 
Effects of Ritalin on task-dependent and taskindependent changes in rCBF
The effects of methylphenidate on rCBF, independent of task conditions, were analyzed using specific contrasts. Consistent with the effects of methylphenidate on glucose metabolism (Volkow et al., 1997) , the drug only produced increases in blood flow in the right cerebellum, but led to decreases in blood flow in regions within the frontal and temporal lobes ( Table 1 ). The loci of task-related effects of methylphenidate on rCBF, as revealed by the significant drug ϫ task interaction, were clearly defined, with changes in rCBF in the dorsolateral prefrontal cortex (DLPFC), supplementary motor cortex, and posterior parietal cortex (PPC)-all in the left hemisphere (Fig. 1) . The adjusted blood flow values for the three regions showing the peak statistical interaction effect between task and drug are displayed in Figure 2a Activation foci represent peaks of corrected statistically significant changes in normalized rCBF (see Materials and Methods). The stereotaxic coordinates are expressed in millimeters. x, Medial-to-lateral distance relative to the midline (positive values ϭ right hemisphere); y, anterior-to-posterior distance relative to the anterior commissure (positive ϭ anterior); z, superior-to-inferior distance relative to the anterior-posterior commissure line (positive ϭ superior).
tions with no effect of methylphenidate on rCBF for the control condition. There were no significant interactions of task difficulty with drug (drug-placebo), and so the easy and difficult conditions were combined for the purpose of illustration (Fig. 2) . The attenuation of activity in the supplementary motor cortex (Fig.  2b) was not predicted on the basis of previous findings (Owen et al., 1996b) , and because the peak interaction effect Z-value (corrected for multiple comparisons) was not significant, it was not analyzed further.
Hemispheric effects of Ritalin on task-dependent changes in rCBF
Previous research has defined regions within the DLPFC and PPC in the right hemisphere as involved in performance of the self-ordered SWM task. The significant interaction between drug and task in the left hemisphere in the present study was, therefore, surprising, although it is consistent with other cognitive psychopharmacological studies using catecholamine agents (Daniel et al., 1991; Grasby et al., 1992; Mattay et al., 1996) . Consequently, supplementary analyses were performed to directly compare the left and right hemisphere drug-induced, taskrelated changes in rCBF within the DLFPC and the PPC.
Repeated-measures ANOVAs showed no interaction of the drug and task with laterality for either the DLPFC (F (1,9) ϭ 2.58; p ϭ 0.14) or the PPC (F (1,9) ϭ 2.76; p ϭ 0.13). Therefore, it appears that the interaction between methylphenidate and the working memory task, although only reaching significance in the left hemisphere according to our statistical criterion, should not be thought of as being unequivocally unilateral. Indeed, closer inspection of these interactions in the equivalent right hemisphere regions revealed decreases in rCBF of Z ϭ 1.61 (DLPFC) and 1.63 (PPC).
Cardiovascular and subjective effects of Ritalin
Subsequent analyses attempted to specify the underlying cognitive, subjective, or cardiovascular processes that might be associated with the enhancement of SWM performance seen after methylphenidate administration. It was predicted that the cognitive effects of methylphenidate would not be related to druginduced effects on subjective or cardiovascular measures. To assess the influence of methylphenidate on changes in subjective mood ratings, responses on a set of 16 visual analog scales (Bond and Lader, 1974) were analyzed using repeated-measures ANOVAs. Because of the number of comparisons being made, a restricted significance threshold of p ϭ 0.01 was used. No significant main effects of drug condition or interactions with drug condition were found. Repeated-measures ANOVA was also used to assess the influence of methylphenidate on the cardiovascular measures of heart rate and blood pressure. A significant effect of drug administration was found for the systolic blood pressure measurements (Table 2 ), but this was not related to the improved performance on the working memory task (Pearson's product moment correlation coefficient, r ϭ Ϫ0.15; p ϭ 0.68).
Relationship of drug-induced enhanced performance to baseline memory span
Prompted by the results of a previous study using a dopamine D2 receptor agonist (bromocriptine) (Kimberg et al., 1997) , the possible relationship between the baseline memory span scores and the drug-induced improvement in SWM performance was investigated. The drug-induced reduction in SWM errors correlated negatively with verbal (r ϭ Ϫ0.78; p ϭ 0.007), as well as spatial (r ϭ Ϫ0.67; p ϭ 0.033) baseline memory span. Thus, subjects with lower baseline memory capacity demonstrated greater improvement in SWM in terms of error reduction after treatment with methylphenidate. In addition, both the digit and spatial memory span scores were highly, positively, correlated (r ϭ 0.78; p ϭ 0.008), suggesting that the drug-induced improvement may be related to general baseline working memory capacity rather than specifically spatial or verbal components.
The drug ؋ task interaction effect on rCBF was not attributable to generalized changes in blood flow
The interaction effects evidenced in this study between methylphenidate administration and SWM task performance were not attributable to generalized effects of methylphenidate on attenuating blood flow (Krimer et al., 1998 ), because they occurred in different loci than the drug-induced changes in rCBF (Table 1) . It is also unlikely that the significant interactions of methylphenidate and the cognitive task on rCBF were artifacts of the overall drug-induced attenuation of rCBF. This is illustrated by the comparison of Figure 2d to Figure 2a -c. Figure 2d shows the adjusted blood flow values for the region of the brain showing the most significant generalized reduction of rCBF in response to methylphenidate administration-the left temporal pole. In Figure 2d methylphenidate administration led to reduced blood flow in both the working memory and the control tasks. This contrasts with the effects for the left DLPFC, left supplementary motor area, and left PPC (Fig. 2a-c) , where reductions in rCBF after methylphenidate were specific to the working memory task conditions. Nor was it the case that all areas of the brain activated by the task were attenuated by methylphenidate. For example, the right ventrolateral prefrontal cortex, which has been shown to be activated by the task (Owen et al., 1996b) , shows no significant drug-induced attenuation in rCBF after drug [mean adjusted blood flow values (with SDs in parentheses) for the stereotaxic coordinates 36, 50, and Ϫ20 for control condition and task conditions: on drug, 56.0 (1.47), 56.5 (0.90); on placebo, 56.5 (1.35), 57.7 (1.36)].
DISCUSSION
The results of this study have demonstrated, we think for the first time, that methylphenidate-induced enhancement of self-ordered SWM performance is accompanied by discrete changes in rCBF within the DLPFC and PPC. These changes were not caused by generalized effects of methylphenidate on rCBF or artifacts of rCBF changes restricted to cortical regions activated by the task. The locus of the interaction effect in the left prefrontal cortex is entirely consistent with other neuroimaging studies investigating the neural correlates of monoaminergic modulation of cognitive functions (Daniel et al., 1991; Grasby et al., 1992; Mattay et al., 1996) . For example, Grasby et al. (1992) showed that the dopamine agonist apomorphine attenuated increased rCBF during a verbal memory task in the left DLPFC which, unlike our study, was accompanied by impaired performance in those on drug. In the present study, the significant methylphenidateinduced reduction of blood flow in the left DLFPC (and the trend in the right DLPFC) therefore appears important for an understanding of the clear enhancement of performance accuracy on the SWM task. Furey et al. (1997) were able to demonstrate a drug-induced speeding of reaction time (but with no effect on performance accuracy) on a facial recognition task after the anticholinesterase physostigmine. This shortening of response latencies was associated with decreased rCBF in the right DLPFC (Furey et al., 1997) . In contrast, studies with catecholaminergic agents, including the present one, have observed task-related modulation of rCBF in the left DLPFC. Moreover, the present enhancement in performance, induced by methylphenidate, was on choice accuracy, whereas physostigmine shortened response latencies (performance accuracy was at ceiling) in a rather different facial recognition paradigm. There are theoretical grounds for concluding that measures of accuracy and latency reflect different aspects of memory retrieval processes (Baddeley, 1986) . Consequently, it would appear that cholinergic and catecholaminergic systems may modulate different aspects of retrieval in the frontal lobes, although further research using a common test procedure would be required to empirically demonstrate such a dissociation.
Because the present task has been shown to preferentially activate the right DLPFC (Owen et al., 1996b) , it is possible that the drug-induced improvement in SWM is mediated by effects on other cognitive processes that modulate performance on this task. One possible mechanism may involve a change in task-related rCBF in the left DLPFC associated with a facilitation of verbal rehearsal via the articulatory loop (Baddeley, 1986) , given that activation in this area has been observed during some verbal The cardiovascular measures of heart rate and systolic and diastolic blood pressure were analysed using MANOVA, which revealed a significant drug ϫ time interaction (F (1.05,8.43) ϭ 5.89; p ϭ 0.039) for systolic blood pressure*. This was caused by subjects on methylphenidate having elevated systolic blood pressure relative to baseline measures compared with those on placebo. SED, SE of the difference of the means, an index of variation for repeated-measures designs as defined by Cochran and Cox (1957) .
working memory tasks (Smith and Jonides, 1998) . Indeed, articulatory suppression is known to impair performance in a spatial reasoning task requiring working memory (Vandierdonck and De Vooght, 1997) and in the task used here (T. W. Robbins, A. M. Owen, V. Foot, and J. Newton, unpublished observations), suggesting some verbal mediation of accurate performance. Alternatively, the drug could be acting to suppress distracting verbal mediation. The lack of evidence for a lateralized effect on rCBF when the two sides are directly compared, together with the finding of a specific relationship of the drug effect to verbal and visual working memory measures, suggest that the drug may be acting on more general working memory processes. The reduction in activation in the DLPFC on drug during the task performance may be related to methylphenidate treatment resulting in an increased efficiency with which the working memory task is completed by a neural network including the DLPFC. The neuronal nature of this increased efficiency may be manifested as an increased response to signals with concomitant suppression of background noise, a well-documented effect of catecholamines (Foote and Morrison, 1975) . Because there were up to 11 distractors present at any stage during the task when the subject was searching for one token, the overall detectable effect of this increase in signal-to-noise ratio may be a reduction in neuronal activity, and hence, a reduction in blood flow in certain regions within the task-specific neural network (Raichle, 1987) . The fact that the subjects with the least effective baseline working memory capacity (tested outside the scanner) exhibited the greatest degree of improvement after methylphenidate is consistent with this account (as can be described by sigmoidal functions of signal discriminability) (Kimberg et al., 1997) .
A number of psychological processes are thought to be involved in the SWM task (Petrides et al., 1993; see also Goldman-Rakic, 1995) and include (1) online storage and active response organization based on the retrieval of information from posterior cortical association systems (involving the mid-ventrolateral prefrontal cortex), and (2) the active manipulation and monitoring of information within working memory (involving the mid-DLPFC). By analogy, the results of the present study can be taken as reflecting selective modulation of (1) the former processes, mediated by drug-induced changes in rCBF in the PPC, and (2) the latter processes mediated by drug-induced changes in rCBF in the left DLPFC. Thus, the findings provide valuable insights into the mechanism of enhancement of SWM performance by the catecholaminergic stimulant drug methylphenidate. These results have important consequences for understanding the methylphenidate-induced improvements seen in children with AD/HD on working memory tasks (Tannock et al., 1995; Kempton et al., 1999) and in comparison with other paradigms (e.g., response inhibition) (Vaidya et al., 1998) . More generally, the results are important for understanding the possible beneficial effects of catecholaminergic drugs in a range of cognitive disorders, including acute brain injury (McDowell et al., 1998) and schizophrenia (Mortimer, 1997) .
